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Abstract 
 
In electron paramagnetic resonance (EPR) dosimetry, solid dosimeter materials such as alanine (AL) or, 
more recently, lithium formate monohydrate (LFM) are typically used. These materials offer high potential 
for applications in radiotherapy based on their favorable dosimetric properties. Nevertheless, EPR 
dosimetry is not widespread in the clinics. This work presents an uncertainty analysis of EPR dosimetry in 
the dose range from 1 to 70 Gy using a compact spectrometer and applying a practical procedure being 
suitable for routine use in radiotherapy. The performances of self-pressed LFM pellets and commercial AL 
pellets are compared side by side.  
All pellets had a diameter of 4 mm and a height of 2 mm (AL) or 4 mm (LFM). The mean pellet mass was 
35.81 mg and 73.81 mg for AL and LFM, respectively. Before irradiation, the pellets were stored for at least 
8 weeks at 34± 2 % relative humidity. For irradiation, the pellets were put inside an airtight capsule. In total, 
25 pellets per material were examined. The pellets were irradiated at a temperature of 25 ± 2.5 (2σ) °C to 
doses of either 1, 5, 20, 50 or 70 Gy (five pellets per dose value and material) by a clinical 6 MV photon 
beam. Measurement uncertainties were obtained from five independent readouts per pellet within five 
weeks following irradiation using a benchtop EPR spectrometer. The measurement time of a single readout 
was restricted to 10 min per pellet. Dose values were derived from EPR signal amplitudes using a specifically 
developed spectral fitting procedure. Signal fading characteristics were analyzed and taken into account 
during evaluation.  
The relative dose uncertainties (1σ) for a single readout at doses ≥ 5 Gy are below 2.8% (AL) and 1.1% (LFM) 
but increase to 12.3% (AL) and 2.6% (LFM) at 1 Gy. By averaging five independent readouts, the 
uncertainties at 1 Gy decrease to 2.6% (AL) and 0.8% (LFM).  
In terms of dose uncertainty, the LFM pellets are superior to the commercial AL pellets owing to their 
narrower EPR spectrum and approximately doubled mass resulting in higher EPR signal intensities. In case 
of the LFM pellets, the EPR dosimetry system shows a high level of precision (< 3%) down to 1 Gy being 
preferable for applications in radiotherapy. The uncertainties can be further decreased by averaging 
multiple dose values from independent readouts.  
 
Keywords: EPR dosimetry, alanine, lithium formate, radiotherapy, uncertainty 
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1. Introduction 
Electron paramagnetic resonance (EPR) spectroscopy is a specific method for the detection of unpaired 
electron spins and has been extensively applied in radiation research (Lund and Shiotani 2014). In 
particular, EPR spectroscopy can be utilized for dosimetry purposes via quantitative analysis of EPR signal 
amplitudes resulting from paramagnetic centers (radicals) induced by ionizing radiation in solid materials 
(Regulla and Deffner 1982, Ikeya 1993, Anton 2005, ISO/ASTM 51607:2013). Usually, solid dosimeters are 
irradiated and then read out on a later occasion (within hours, days or even weeks) featuring a passive, 
off-line procedure. Since the EPR readout does not affect the radical concentration (non-destructive) in 
the sample, repetitive readouts are feasible.  
EPR dosimeter materials should meet the following two basic requirements: i) Persistent radicals are 
created via irradiation and ii) the radical concentration increases monotonously with the absorbed 
radiation dose. Ideally, EPR dosimetry materials show a linear dependency of the radical concentration 
on the absorbed dose and low recombination rates, i.e. slow EPR signal fading.    
One of the first and most intensively studied EPR dosimeter materials is polycrystalline L-alanine (AL) 
(Gordy et al 1995, Bradshaw et al 1962). AL forms very stable radicals upon irradiation (Regulla and 
Deffner 1982, Arber and Sharpe 1993) and the amount of radicals increases linearly with dose up to 5 kGy 
(Nagy 2000). Alanine dosimetry is commonly applied in high dose (kGy) applications such as radiation 
processing and sterilization (Wieser and Regulla 1989, McLaughlin and Desrosiers 1995). In this dose 
range, elaborated dosimetry guidelines exist (ISO/ASTM 51607:2013). Further remarkable features of AL 
are its high water equivalence and the minor dependencies of its EPR response on beam energy 
(Waldeland and Malinen 2011), dose rate (Desrosiers et al 2008) and beam angle for therapeutic MV 
photon beams. These properties offer high potential for applications in external beam radiotherapy 
(EBRT) (Baffa and Kinoshita 2014).  
Due to its favorable characteristics, several researchers have successfully applied alanine dosimetry in 
EBRT, especially for challenging dosimetry tasks such as In-vivo dosimetry (Wagner et al 2008, Schaeken 
et al 2010, Wagner et al 2017), small-field dosimetry (Garcia et al 2011, Vega Ramirez et al 2011), mailing 
dosimetry audits (Schaeken et al 2011) and intercomparisons (De Angelis et al 2005), FLASH-radiotherapy 
(Bourhis et al 2019) and dosimetry in magnetic fields (Billas et al 2020). Nowadays, several national 
institutes use alanine dosimeters as a secondary standard with a dose uncertainty (1σ) of less than 1% for 
doses above 5 Gy (Sharpe et al 1996, Anton 2005, 2006). By following these sophisticated measuring and 
evaluation procedures, precise dose measurements with alanine can be achieved. EPR dosimetry is thus 
an attractive technique with a wide range of potential applications in radiotherapy. 
However, routine use of EPR dosimetry is not widespread in radiotherapy – presumably due to the 
reported increase in uncertainty at the 1 Gy dose level (Sharpe et al 1996, Anton 2006, Helt-Hansen et al 
2009), the high costs for the investment and the space requirements of generally large-sized EPR 
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spectrometers as well as the associated efforts of precise dose measurements. Against this background 
the question arises whether a practical and cost-efficient EPR dosimetry system utilizing a benchtop 
spectrometer in combination with more sensitive dosimeters may meet the accuracy requirements in 
radiotherapy.  
In the past two decades and in order to decrease the lower limit of detection, novel EPR dosimeter 
materials like lithium formate monohydrate (LFM) have been proposed (Lund et al 2002, Vestad et al 
2003, Lund et al 2005) and tested for dosimetry in EBRT (Vestad et al 2004, Waldeland et al 2010, 
Adolfsson et al 2014a, 2019) at doses around 1 Gy. Compared to AL, EPR dosimetry with LFM is more 
sensitive since LFM provides higher EPR signal intensities for equal dose (Lund et al 2002, Vestad et al 
2003) - primarily due to its narrower EPR spectrum. In terms of the effective atomic number (Vestad et al 
2003) and the energy dependence of the mass energy absorption coefficient (Lund et al 2002) as well as 
the mass stopping power relative to water (Vestad et al 2004, Gustafsson et al 2008), LFM is even more 
water-equivalent than AL featuring lower beam energy dependence (Waldeland and Malinen 2011) - 
especially for kV beam qualities.  
It is well known that the achievable level of uncertainty in EPR dosimetry is primarily depending on the 
dose level, the dosimeter material and its mass. In addition, the equipment used for readout as well as 
the measuring protocol and the spectral evaluation technique play an important role. It is therefore 
imperative to elucidate the actual dose uncertainty for a specific EPR dosimetry system consisting of 
dosimeters, EPR spectrometer, measuring protocol and spectral evaluation procedure. There is still a 
strong need to thoroughly improve, analyze and report uncertainty levels as performance characteristic 
of EPR dosimetry – especially for the novel dosimeter materials like LFM.  
The purpose of the current work is to examine and to optimize the dose uncertainties of EPR dosimetry 
in the dose range from 1 to 70 Gy by using a compact and practical EPR dosimetry system – as being 
suitable for on-site clinical routine application in EBRT. A specific data post-processing procedure is 
developed for spectral evaluation. In terms of uncertainties, a direct comparison between self-pressed 
LFM pellets and commercial AL pellets is presented.  
 
2. Material and Methods 
2.1 Dosimeter preparation and storage 
The AL pellets were received from Aérial (Illkirch, France), whereas the LFM pellets were manufactured 
in-house. Lithium formate monohydrate 98% was purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Before pressing, the powder was roughly ground with a pestle and mortar. Afterwards, the powder was 
portioned by weight and pressed by means of a hydraulic tablet press (Bodenseewerk Perkin-Elmer, 
Überlingen, Germany) without the use of additional binder material. All pellets had a diameter of 4 mm 
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and a height of 2 mm (AL) or 4 mm (LFM). The mean pellet mass was 35.81±0.13(2σ) mg and 
73.81±0.76(2σ) mg for AL and LFM, respectively. In total, 25 pellets per material were prepared and stored 
at constant room temperature inside an air-tight box that provided shielding from daylight as well as a 
constant level of 34±2% relative humidity (RH). The relative humidity was controlled by a saturated 
aqueous solution of MgCL2 covering the bottom of the storage box.  All pellets were stored for at least 8 
weeks prior to irradiation in order to achieve an equal level of moisture content among all pellets.  
2.2 Irradiation 
For irradiation, the pellets were placed in a cylindrical air-tight polyethylene capsule with an inner and 
outer diameter of 4 mm and 6.4 mm, respectively. Synthetic rubber plugs served as sealing. Every capsule 
contained two pellets - one of each type - as shown in figure 1(a).  
 
 
Figure 1. Cylindrical polyethylene dosimeter capsule containing one AL and one LFM pellet (a). 
Synthetic rubber plugs are shown as black parts. Irradiation setup utilizing a solid water slab 
phantom (b). 
 
The EPR capsules were put at 10 cm depth inside a solid water slab phantom (15 cm x 55 cm x 21 cm) and 
positioned on the central axis of a clinical 6 MV flattening filter free (FFF) photon beam of a Tomotherapy® 
Hi-Art® (Accuray, Sunnyvale, CA, USA) treatment machine (figure 1(b)). A maximum field size of 5 cm x 
40 cm and 85 cm source surface distance (SSD) was chosen. Irradiation was applied in two subsequent 
fractions. In between, the capsules were rotated by 180°.  In total, 25 capsules were irradiated and five 
different nominal doses were applied: 1, 5, 20, 50 or 70 Gy. At each dose level, 5 capsules were irradiated. 
Absolute dose measurements were performed with a calibrated A1SL (Standard Imaging, Middleton, WI, 
USA) reference ionization chamber considered as the ground truth and the real absolute dose values 
obtained were: 0.986, 4.926, 19.694, 49.242 and 68.924 Gy.  
The diameter of the phantom holes at 10 cm depth matched the outer diameter of the ionization chamber 
and EPR capsules. The temperatures of the capsules during irradiation were within 25 ± 2.5 (2σ) °C.  
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After irradiation, the pellets were stored at room temperature inside the storage box (see section 2.1). 
One additional capsule was irradiated to 273 Gy to obtain a high signal-to-noise (SNR) AL spectrum for 
evaluation purposes (see section 2.4).  
2.3 EPR readout 
Continuous wave (CW) EPR measurements were performed on a benchtop EPR spectrometer operating 
in X-band (MiniScope MS 5000, Magnettech by Freiberg Instruments GmbH, Freiberg, Germany). A 
magnetic field sweep width of 15 mT, a 100 kHz modulation with amplitude of 0.8 mT (overmodulation in 
order to increase the SNR) and a microwave power of 2 mW were applied. The microwave power setting 
assured operation in the linear regime, where the EPR intensity increases linearly with the square root of 
the microwave power (Eaton et al 2010) for both the reference and the pellet signal. Since the handling 
of the pellets may result in a small mass loss, every pellet mass was determined with an analytical balance 
(Kern ABT 120-5DM, Kern & Sohn GmbH, Balingen-Frommern, Germany) right before EPR readout. In 
order to position each pellet in the center of the resonator, a dedicated sample holder system (figure 2) 
was used. Each pellet was inserted into a cylindrical quartz tube (hereinafter referred to as the ‘sample 
tube’) with an inner diameter of 4.1 mm. Two different sample tubes were used – one for each dosimeter 
material. The pellets were supported by an PTFE insert that was affixed to the bottom of each sample 
tube. This insert ensured central positioning of each pellet within the sample tube and prevented possible 
horizontal tilts. The PTFE inserts differed in height to compensate for the different heights of the two 
pellet types. The sample tube containing the PTFE insert and the pellet was then inserted into the tube 
holder with a fixed axial orientation. The tube holder minimized lateral and horizontal variations in 
positioning between different readouts. During each readout, 10 subsequent scans were acquired and 
averaged without rotating the sample tube. Auto tuning of the resonator coupling between the scans was 
enabled. The time for one scan was set to 60 s resulting in a measurement time for a single readout of 
about 10 min per pellet. In order to examine the reproducibility of EPR signal amplitudes, each pellet was 
readout on a weekly basis within the first five weeks following irradiation.  
A manganese (ZnS:Mn2+) reference substance (Magnettech by Freiberg Instruments GmbH, Freiberg, 
Germany) was introduced into the resonator from the side of the spectrometer (figure 2) serving as an 
intensity reference signal during readouts. In general, the spin S=5/2 system of Mn2+ provides a six-line 
EPR spectrum. In this work, the middle two EPR lines were recorded by the applied magnetic field sweep.  
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Figure 2. Schematic sketch of the setup during EPR readout showing the sample holder system 
containing the pellet and the position of the manganese reference.  
 
2.4 Spectral evaluation 
In EPR dosimetry, the EPR signal amplitudes of irradiation induced radical spectra are evaluated. For 
precise dose measurements, the determined amplitudes need to be corrected for several influence 
quantities outlined in the following. Regarding the spectrometer performance, the constancies of the 
modulation amplitude, microwave power, resonator quality factor Q as well as sensitivity fluctuations of 
electronic components may affect the reproducibility of absolute EPR intensities. In order to compensate 
for these possible instabilities, the relative amplitude of the radical spectrum with respect to the 
amplitude of a well-known reference substance is typically used for precise dose measurements (Nagy et 
al 2000a, Anton 2005).  In the current work, a Mn2+ reference substance was simultaneously measured 
with each pellet and served as intensity reference as well as for microwave frequency normalization of 
the measured spectra. As a consequence, the resulting total EPR spectrum S is essentially composed of 
the pure radical spectrum R, which is the one of primary interest, and the Mn2+ spectrum Mn. The 
amplitudes of the reference signal Mn and the radical signal R were evaluated via fitting of pre-known 
base spectra (RB, MnB) to the composite spectrum S. The final fit coefficients a and b reflect the amplitude 
modification factor of RB and MnB, respectively, and result from a least-squares optimization. The spectral 
fitting procedure was implemented in MATLAB® (MathWorks, Nattick, MA, USA) and is exemplarily 
illustrated in figure 3 for AL. 
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Figure 3. Example of the spectral fitting procedure for an AL pellet (40 Gy). Measured composite 
spectrum S (black) and base spectra: ALB (red) and MnB (blue) (top). Resulting fit (green) 
(middle). Extracted pure AL spectrum (purple) (bottom). 
 
The pure radical base spectra RB were reconstructed from measurements of high SNR spectra (273 Gy for 
AL and 70 Gy for LFM). These dose values yield comparable SNR for both pellet types. The manganese 
base spectrum MnB was acquired for 1h on each measurement day and for each material (AL and LFM) 
with a respective non-irradiated pellet inserted in the sample holder system. The MnB base spectrum 
included, in addition to the pure Mn spectrum, small EPR signal contributions from the resonator, the 
tube holder, the sample tube and its PTFE insert as well as the native pellet signal.  
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In summary, the total EPR spectrum S is primarily to be seen as a superposition of RB and MnB.  
Additionally, the EPR spectrum is affected by a small, random, non-linear signal that varies between 
different readouts (Nagy et al 2002) and constitutes the residual signal (RES). All contributions are 
summarized in equation (1).  
 
𝑆 = 𝑎 𝑅𝐵 + 𝑏 𝑀𝑛𝐵 + 𝑅𝐸𝑆        (1) 
 
𝐴𝐷 =
𝑎
𝑏
𝐷𝐵
𝑚𝐵
𝑚
𝑘𝑡𝑘𝑇
𝑘𝑡′
𝐵 𝑘𝑇′
𝐵  ∝   𝐷𝑖𝑟𝑟      (2)  
 
The spectrometer instabilities are cancelled out when taking the ratio of the final fit coefficients (a/b) for 
further analysis. This ratio is then multiplied by the known dose value of the RB spectrum DB (2). Further 
corrections concerning the sample mass m with respect to mB (mass of the pellet used to obtain RB) as 
well as consideration of temporal fading kt and the irradiation temperature kT need to be taken into 
account. By this means, the so called dose normalized amplitude AD (Anton 2006) is obtained that 
correlates more precisely with the irradiation dose Dirr (2) than the untreated final fit coefficient a.  
In the present work, AD does not include corrections for varying irradiation temperature since the effect 
is minor for the temperature differences encountered during irradiation (section 2.2). However, the effect 
is considered during the uncertainty analysis (section 2.5).  
Temporal fading is a known effect in EPR dosimetry. Therefore, precise EPR dosimetry protocols correct 
for the associated signal loss over time. Fading rates may depend on the manufacturing process (Anton 
2008) as well as on the pre- and post-irradiation storage conditions (Arber and Sharpe 1993, Dolo and 
Feaugas 2005). Hence, fading measurements need to be performed for each specific type of pellet and 
the applied storage conditions. 
In case of AL, the AL base spectrum RB was recorded only once on the first measurement day since no 
temporal changes in line shape were observed. The amplitude of the current MnB spectrum was fitted to 
the respective spectrum obtained on the first measurement day. The spectral fitting procedure was 
performed with the amplitude adjusted, current MnB spectrum and RB. Amplitude fading corrections were 
applied according to 
𝑘𝑡
𝑘𝑡′
𝐵 = 𝑓 ∙  (𝑡 − 𝑡
′). The fading rate 𝑓 was assumed to be constant. It was estimated 
from follow-up measurements of the 70 Gy AL pellets within 4 months after irradiation.  
For LFM, an up-to-date base spectrum RBc was derived by averaging the mass-corrected 70 Gy spectra 
acquired on each measurement day in order to consider possible changes in line shape over time. The 
fitting procedure described above was then performed with the current base spectra (MnB, RBc). Hence, 
fading corrections were inherently included in the LFM analysis (𝑘𝑡′
𝐵 = 𝑘𝑡, since 𝑡 = 𝑡′). 
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During fitting, the random residual signal RES was modeled by a 2nd order polynomial function.  
A calibration curve (AD vs. Dirr) was obtained by a linear (3) or quadratic regression model (4). The data 
points were weighted by 1/Dirr. (𝑙1, 𝑙0) and  (𝑞2, 𝑞1, 𝑞0) are the resulting regression coefficients for the 
linear and quadratic model, respectively. 
 
𝐴𝐷 =  𝑙1 𝐷𝑖𝑟𝑟 + 𝑙0      (3) 
 
𝐴𝐷 =  𝑞2 𝐷𝑖𝑟𝑟
2 + 𝑞1 𝐷𝑖𝑟𝑟 + 𝑞0      (4) 
 
Calibration is needed for later estimation of unknown doses 𝐷𝑊
𝐶  via the inverse functions (5) or (6), 
respectively . 
 
 𝐷𝑊
𝐶 =
𝐴𝐷
𝑙1
−
𝑙0
𝑙1
       (5) 
 
 𝐷𝑊
𝐶 =
1
2𝑞2
(√𝑞1
2 + 4𝑞2(𝐴𝐷 − 𝑞0) − 𝑞1)    (6) 
 
2.5 Uncertainty analysis 
In this work, a EPR dosimetry system is calibrated against the reading from a calibrated reference 
ionization chamber. The stated uncertainties reflect the precision of the EPR dosimetry system. For 
consideration of accuracy, the uncertainty of the ionization chamber calibration and the reference 
dosimetry procedure need to be taken into account additionally.  
All measurement uncertainties in this work are determined and expressed in accordance to the Guide to 
the Expression of Uncertainty in Measurement published by the International Organization for 
Standardization (BIPM 2008). Unless otherwise stated, all uncertainties are given as standard 
measurement uncertainties (1σ). 
In order to perform a Type A uncertainty analysis of the presented dosimetric procedure, a set of 
25 dosimeter capsules were irradiated and evaluated five times (section 2.2). The determined relative 
uncertainty (𝑢𝑟(𝐴𝐷
𝑚)) for a single readout at each dose level is an estimate of the standard deviation 
among the 𝑛 = 25 𝐴𝐷 -values (five different pellets measured five times). The relative standard error 
𝑆𝐸𝑟 of this estimate is in good approximation given by 𝑆𝐸𝑟 =  𝑢𝑟(𝐴𝐷
𝑚)/√2(𝑛 − 1) (Harding et al 2014).  
A Type B uncertainty analysis was conducted by the consideration of error propagation starting from the 
formulas that were used to determine AD (2) and the final Dose 𝐷𝑊
𝐶  (5), (6). 
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𝑢(𝐴𝐷
𝐶 )
2
= 𝑢(
𝑎
𝑏
)2 + 𝐴𝐷
2 [𝑢𝑟(𝑚)
2 + 𝑢𝑟(𝐷)
2 + (
𝑑𝑘𝑇
𝑑𝑇
𝑢(𝑇))
2
]    (7) 
 
𝑢(𝐷𝑊
𝐶 ) =
1
𝑙1
√𝐷𝑊
𝐶 2𝑆𝐸(𝑙1)2 + 𝑆𝐸(𝑙0)2 + (𝑢(𝐴𝐷))2 + 2𝐷𝑊
𝐶 𝑐𝑜𝑣(𝑙1, 𝑙0)   (8) 
 
𝑢(𝐷𝑊
𝐶 ) = √(
𝜕𝐷𝑊
𝐶
𝜕𝐴𝐷
𝐶 )
2
𝑢(𝐴𝐷
𝐶 )2 + ∑ (
𝜕𝐷𝑊
𝐶
𝜕𝑞𝑖
)
2
𝑆𝐸(𝑞𝑖)2 +𝑖 2 ∑
𝜕𝐷𝑊
𝐶
𝜕𝑞𝑖
𝜕𝐷𝑊
𝐶
𝜕𝑞𝑗
𝑖,𝑗 𝑐𝑜𝑣(𝑞𝑖, 𝑞𝑗)(1 − 𝛿𝑖𝑗)              (9) 
 
𝜕𝐷𝑊
𝐶
𝜕𝐴𝐷
𝐶 = −
𝜕𝐷𝑊
𝐶
𝜕𝑞0
= (2𝑞2𝐷𝑊
𝐶 + 𝑞1)
−1
                (10) 
 
𝜕𝐷𝑊
𝐶
𝜕𝑞1
= −
𝐷𝑊
𝐶
2𝑞2𝐷𝑊
𝐶 +𝑞1
                  (11) 
 
𝜕𝐷𝑊
𝐶
𝜕𝑞2
=
1
𝑞2
(
𝐴𝐷−𝑞0
2𝑞2𝐷𝑊
𝐶 +𝑞1
− 𝐷𝑊
𝐶 )                 (12) 
 
The following estimations concerning the uncertainty budget were made: the standard uncertainty (1σ) 
of the pellet mass is 𝑢(𝑚) = 0.05 𝑚𝑔  ( 𝑢𝑟(𝑚) = 0.13% (𝐴𝐿), 𝑢𝑟(𝑚) = 0.06% (𝐿𝐹𝑀) ), the 
reproducibility of irradiation is 𝑢𝑟(𝐷) = 0.2% and the uncertainty contributions from varying irradiation 
temperatures are 
𝑑𝑘𝑇
𝑑𝑇
𝑢(𝑇) = 0.20% (𝐴𝐿),
𝑑𝑘𝑇
𝑑𝑇
𝑢(𝑇) = 0.19% (𝐿𝐹𝑀)  with 𝑢(𝑇) = 1.25 𝐾  and 
𝑑𝑘𝑇
𝑑𝑇
=
0.161%/𝐾 for AL or 
𝑑𝑘𝑇
𝑑𝑇
= 0.154%/𝐾 for LFM (Waldeland et al 2011). The uncertainty of the analyzed 
EPR amplitudes 𝑢(
𝑎
𝑏
) was determined by a least-squares fit of 𝑢𝑟(𝐴𝐷
𝐶 ) to the measured uncertainties 
𝑢𝑟(𝐴𝐷
𝑚) (section 3.3) for each material. Overall, the uncertainty of the dose normalized amplitude 𝑢(𝐴𝐷
𝐶 ) 
is given by (7). 
In a second step, when the irradiation dose is unknown, the fit coefficients obtained via calibration can 
be applied to calculate the dose 𝐷𝑊
𝐶  from measured 𝐴𝐷-values via (5) or (6), respectively. In order to 
calculate the resulting standard uncertainty 𝑢(𝐷𝑊
𝐶 ), the standard errors SE of the regression coefficients 
and their covariances cov need to be considered as well. Equation (8) shows the formula in case of a linear 
regression model. The corresponding formula for the quadratic model is likewise obtained through error 
propagation (9) - (12).  
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3. Results 
Post-processed (section 2.4) EPR spectra of AL and LFM pellets irradiated to 70 Gy are depicted in figure 
4 for comparison. The amplitudes were corrected for the pellet mass in order to show the effect of the 
dosimeter material on the EPR signal amplitude and the spectral width.  
Irradiation induced radicals in LFM reveal a narrower EPR spectrum than AL radicals. Moreover, the LFM 
peak-to-peak amplitudes are about twice as high when comparing LFM and AL pellets of equal dose and 
mass.  
 
Figure 4. Comparison of mass corrected AL and LFM EPR spectra obtained from pellets irradiated 
to 70 Gy. The intensities are normalized to the maximum of the AL EPR spectrum. 
 
3.1 Temporal fading 
Long-term measurements were conducted for the 70 Gy pellets in order to examine the EPR signal loss 
after irradiation as a function of time. In case of AL, low fading rates extrapolated to about 𝑓 = 3%/𝑎 
were obtained (data not shown) and no changes in EPR line shape were observed. For LFM, however, 
notable temporal changes in line shape were detected. Figure 5 shows the base spectra reconstructed 
from the 70 Gy spectra recorded on day 4, day 32 and day 67 after irradiation. The EPR spectral width of 
irradiated LFM pellets decrease slightly during the first five weeks following irradiation (day 4 vs. day 32) 
gradually approaching a steady line shape (day 32 vs. day 67). In turn, the peak-to-peak signal amplitudes 
increase by about 3% with respect to the initial spectrum (day 4) within the first five weeks. These 
temporal changes in line shape and peak-to-peak amplitude were considered during the evaluation of 
LFM spectra by using an updated LFM base spectrum on each measurement day (section 2.4).  
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Figure 5. Comparison of spectral line shapes and amplitudes of LFM base spectra (70 Gy) 
recorded at different time points after irradiation. The amplitudes are normalized to the 
maximum signal intensity of the initial spectrum (day 4).  
 
3.2 Calibration 
In total, 125 readouts were performed for each dosimeter type, i.e. 25 readouts per dose level. The 
resulting dose values (𝐴𝐷) obtained by the elaborated EPR dosimetry procedure are shown in the top 
graphs of figure 6 for AL (left) and LFM (right). Both dosimeter materials show a nearly linear dependency 
between the measured dose values and the irradiation dose (𝐷𝑖𝑟𝑟). The displayed line indicates a true 
linear dependency (𝐴𝐷 = 𝐷𝑖𝑟𝑟).  
Relative variability of the 𝐴𝐷  values around this line is depicted in the middle graphs of figure 6 
highlighting the increase in relative variance at lower doses. Linear (lm) and quadratic models (qm) 
obtained via regression analysis are shown as blue and purple curves, respectively. The mean relative 
residuals as well as the 95% confidence bounds of the respective model are given in the bottom graphs of 
figure 6. The error bars indicate the standard errors of the mean relative residuals (SEM). In case of AL, 
the linear model predicts the mean 𝐴𝐷 -value adequately, as the mean relative residuals (± SEM) are 
located within the 95% confidence bounds for all dose levels. This situation is different for the LFM data. 
Here, the mean relative residuals of the linear model lie outside of the confidence bounds. As a 
consequence, a quadratic model was chosen which predicts the mean 𝐴𝐷-values more accurately, i.e. for 
the quadratic model, the mean relative residuals (± SEM) are located within the 95% confidence bounds.  
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Figure 6. Calibration results for AL (left) and LFM (right). Determined dose normalized amplitudes 
AD vs. irradiation dose Dirr (black circles) and straight line through the origin with slope 1 (brown) 
(top row). Ratios AD/Dirr vs. Dirr (black circles) and fitted linear (blue) and quadratic (purple) 
models (middle row). Relative mean deviations (residuals) of the data points from the respective 
fit and 95% confidence bounds of the model (bottom row). The error bars indicate the standard 
errors of the mean residuals.  
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Detailed results of the regression analysis are listed in table 1. The standard errors (SE) of the fit 
coefficients and the covariances reflect the uncertainty of calibration. Next, these uncertainties 
contribution are taken into account for a complete uncertainty analysis of the dosimetric procedure. 
 AL LFM 
Model linear linear Quadratic 
Regression 
coefficients 
𝑙1 𝑙0 𝑙1 𝑙0 𝑞2 𝑞1 𝑞0 
1.006 -0.019 1.000 -0.043 2.2 e-4 0.987 -0.020 
Standard 
error 
𝑆𝐸(𝑙1) 𝑆𝐸(𝑙0) 𝑆𝐸(𝑙1) 𝑆𝐸(𝑙0) 𝑆𝐸(𝑞2) 𝑆𝐸(𝑞1) 𝑆𝐸(𝑞0) 
0.001 0.013 0.001 0.007 3 e-5 0.002 0.007 
Covariance 
𝑐𝑜𝑣(𝑙1, 𝑙0) 𝑐𝑜𝑣(𝑙1, 𝑙0) 𝑐𝑜𝑣(𝑞2, 𝑞1) 𝑐𝑜𝑣(𝑞1, 𝑞0) 𝑐𝑜𝑣(𝑞2, 𝑞0) 
-5.54 e-6 -1.63 e-6 -0.05 e-6 -6.54 e-6 0.10 e-6 
Table 1. Results of the linear and quadratic prediction models resulting from regression analysis 
of AL and LFM data.   
3.3 Uncertainty analysis 
Relative standard deviations 𝑢𝑟(𝐴𝐷
𝑚) were estimated from the 25 measurements at each dose level and 
for each dosimeter type. The results are shown in figure 7 for AL (a) and LFM (b) as black circles. As can 
already be seen in figure 6, the scattering of the 𝐴𝐷values increases with decreasing irradiation dose for 
both dosimeter types. In figure 7, a rapid increase in the standard deviation is observed at doses below 5 
Gy. At the 1 and 5 Gy dose level the relative uncertainty  𝑢𝑟(𝐴𝐷
𝑚) is considerably smaller for LFM (by a 
factor of about 4) compared to AL. At higher dose levels (>20 Gy) a relative uncertainty 𝑢𝑟(𝐴𝐷
𝑚) < 0.7% 
was observed for both materials.  
Equation (7) was applied to estimate the uncertainty of the 𝐴𝐷  values 𝑢𝑟(𝐴𝐷
𝑐 ) from the uncertainty 
budget for arbitrary dose values within the investigated dose range. In case of AL, a dose independent 
contribution of 0.13 Gy was assumed reflecting the uncertainty of the analyzed EPR signal amplitudes 
𝑢(
𝑎
𝑏
), i.e. the sensitivity of the dosimetry system. For LFM, 𝑢(
𝑎
𝑏
) was set to 0.03 Gy (about a factor of 4 
smaller). The 𝑢𝑟(𝐴𝐷
𝑐 )  values thus obtained (cyan dots in figure 7) are within the error range of the 
experimental values. The constant contribution to uncertainty 𝑢(
𝑎
𝑏
)  is the dominant uncertainty 
contribution at low doses (<20 Gy). It is attributed to a random residual signal. This conclusion is supported 
by the fact, that the uncertainty can be reduced considerably by averaging multiple 𝐴𝐷values obtained at 
different days. The red points in figure 7 show the resulting uncertainties when five 𝐴𝐷values - obtained 
for the same pellet on different days - are averaged.  
Since the comparison of the uncertainties associated with the AL and LFM pellets is biased by the fact that 
the LFM pellets contain approximately twice as much active material than the AL pellets, relative 
uncertainties 𝑢𝑟(𝐴𝐷
𝑐 )  for AL pellets having the same mass as the LFM pellets were derived from equation 
(7) by setting  𝑢(
𝑎
𝑏
) to 0.06 Gy and 𝑢𝑟(𝑚) to 0.06%. The results are represented by the grey line in figure 
7 (a). 
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The final relative uncertainty 𝑢𝑟(𝐷𝑤
𝑐 ) of the EPR dosimetry system is represented by the blue curves in 
figure 7 taking into account additionally the uncertainty of the fit coefficients obtained from the 
regression analysis. However, this contribution turns out to be marginal (𝑢𝑟(𝐷𝑤
𝑐 ) - 𝑢𝑟(𝐴𝐷
𝑐 ) <0.1%) for both 
materials.  
In summary, the relative dose uncertainties for a single EPR readout at doses ≥ 5 Gy are below 2.8% (AL) 
and 1.1% (LFM) but increase to 12.3% (AL) and 2.6% (LFM) at 1 Gy. By averaging five independent 
readouts, the uncertainties at 1 Gy decrease to 2.6% (AL) and 0.8% (LFM). When AL pellets with the same 
mass as the LFM pellets are used, the rel. uncertainties for AL are expected to decrease to 6.2% at 1 Gy 
and stay below 1.3% at doses above 5 Gy. 
 
 
Figure 7. Analysis of relative uncertainty for AL (a) and LFM (b). Measured relative uncertainties 
(black circles), estimated relative uncertainties from the uncertainty budget (cyan dots) and final 
uncertainty including the uncertainties from the regression analysis (blue lines). The red dots 
represent the measured uncertainty when five dose values (𝐴𝐷) from different readouts are 
averaged. Expected rel. uncertainty for AL pellets with same mass as the LFM pellets (grey line 
in (a)).  
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4. Discussion 
The current work presents a practicable EPR dosimetry system being suitable for on-site measurements 
in clinical routine. A thorough investigation on the dosimetric performance of an elaborated dosimetry 
procedure was conducted for AL and LFM dosimeters in the dose range from 1 to 70 Gy using a benchtop 
EPR spectrometer. 
For doses above 20 Gy, similar levels of precision were found for LFM (𝑢𝑟(𝐷𝑤
𝑐 ) < 0.5%) and AL (𝑢𝑟(𝐷𝑤
𝑐 ) < 
0.7%). At lower doses (<20 Gy), however, a significantly higher precision was observed for the self-pressed 
LFM pellets compared to the commercial AL pellets (figure 7). Relative measurement uncertainties are 
known to increase with decreasing dose (i.e. EPR signal amplitudes), especially in the therapy dose range 
(Anton 2006). The higher precision for LFM pellets is attributed to the increased EPR signal intensities that 
can be explained by the following facts: i) The mass of the actual LFM dosimeters was about twice the AL 
pellet mass resulting in higher EPR intensities due to the approximately doubled amount of radical species. 
ii) The radical yield (𝐺-value) is slightly larger (𝐺LFM/𝐺𝐴L ≈ 1.1). iii) The width of the EPR spectrum is 
considerably smaller for LFM (figure 4). In general, a smaller spectrum results in higher EPR intensities, 
given the same amount of radicals in the sample. Here, the peak-to-peak intensities of LFM spectra are 
about two times higher compared to AL (figure 4) which is in good agreement with earlier reports 
(Komaguchi et al 2007). In total, these facts result approximately in a four times higher peak-to-peak 
amplitude for our LFM pellets when equal dose spectra are compared.  
Experimentally obtained relative uncertainties were explained by a Type B uncertainty analysis (figure 7) 
throughout the investigated dose range. The analysis showed that a constant, dose independent term 
𝑢(
𝑎
𝑏
) (7) is responsible for a sharp increase in relative uncertainty at low doses (< 20 Gy).  𝑢(
𝑎
𝑏
) reflects the 
uncertainty of the EPR signal amplitudes resulting from the spectral fitting procedure. It is primarily 
attributed to small variations in the empty tube EPR spectrum arising from positional variations of the 
sample tube. We found that 𝑢(
𝑎
𝑏
) expressed in terms of dose is 0.03 Gy for LFM and 0.13 Gy for AL, i.e. by 
a factor of about 4 smaller for LFM. The latter finding can be explained by the four times higher peak-to-
peak amplitude of the LFM pellets. If AL pellets with the same mass as the LFM pellets are used, 𝑢(
𝑎
𝑏
) is 
expected to decrease to about 0.06 Gy resulting in reduced rel. uncertainties for AL (figure 7 (a)).  
Our analysis suggests that the main uncertainty contribution at low doses originates from the residual 
signal with an average EPR signal amplitude that is independent of the dosimeter material. Moreover, 
averaging over several dose values obtained from the same pellet on different days resulted in a 
considerable decrease in relative uncertainty at low doses (figure 7). In previous works, the main 
contribution to 𝑢(
𝑎
𝑏
) was attributed to inter-pellet variations in the native pellet signals (Wieser et al 1993, 
Haskell et al 1998, Anton 2005 and others). Anton, for example, determined 𝑢(
𝑎
𝑏
) to be in the order of 20 
mGy for AL due to inter-pellet signal variations (Anton 2005). Based on the findings of our experiments, it 
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is concluded that for our dosimetry system the main contributions to the residual signal is not based on 
inter-pellet variations in the native pellet signals, but is rather due to geometric variations of the empty 
tube (as mentioned above), low frequency noise of the utilized EPR spectrometer, as well as signal 
anisotropy. Similar findings were reported earlier by Nagy (Nagy et al 2002). We therefore observed that 
the dose uncertainty could be considerably reduced when several independent readouts of the same 
pellet were averaged, but at the expense of practicability. Another approach of improving measuring 
reproducibility is averaging over several measurements performed at different angles by rotating the 
sample tube in between measurements. This technique is used by most of the calibration laboratories 
that make high accuracy measurements with alanine dosimeters (e.g. Anton 2005). Similar to the 
procedure presented in this study, it is expected that rel. measurement uncertainties can be further 
decreased by averaging the results of spectra acquired under different tube angles, since positional 
variations of the sample tube constituting the random residual signal will likewise be averaged out. 
In summary, the dose dependency of the relative uncertainty (figure 7) is explained as follows:  The 
relative amplitude of the residual signal with respect to the radical signal increases for low doses (∝1/D) 
thus leading to an increase in relative uncertainty. For higher doses, the contribution of the residual signal 
to relative uncertainty is minor. Here, the other contributions in equation (7) are dominant giving rise to 
a constant level of relative uncertainty.  
In case of LFM, the measured uncertainties of the dosimetry system presented in this work are only 
slightly higher than the uncertainties stated by national metrology institutes (NMIs) for AL dosimeters: At 
the 5 Gy dose level, relative uncertainties achieved by alanine dosimetry at NMIs are 0.6% (Anton 2006) 
and 1% (Sharpe et al 1996). At this dose level, we observed a relative uncertainty of 2.8% for AL and 1.1% 
for LFM. The higher level of precision at the German NMI (Physikalisch-Technische Bundesanstalt (PTB)) 
is obtained by the use of a large-size spectrometer in combination with a high-sensitivity resonator, AL 
pellets of higher mass (60 mg), a goniometer for rotating the sample tube and daily calibration of the 
dosimetry system (Anton 2006) resulting in a time-consuming procedure (~8 h). The procedure proposed 
in this work is tailored to efficiency and expediency aiming at routine application in clinical routine. It 
requires only moderate effort through one-time calibration, considerably less space (benchtop 
spectrometer) and features a convenient and short measuring protocol (readout time 10 min per pellet 
without rotating the pellet between scans). The manganese base spectrum MnB needs to be acquired 
once on each measurement day.  
When necessary, dose uncertainties can be further improved by averaging independent readouts (e.g. 
𝑢𝑟(𝐷𝑤
𝑐 ) for LFM is below 1% throughout the investigated dose range when five readouts are averaged, 
figure 7). The effect of averaging multiple readouts of LFM dosimeters was investigated previously 
(Adolfsson et al 2014b) and a significant reduction in relative uncertainty was thereby achieved for low 
signal amplitudes. Relative uncertainties may be even further decreased by using high purity LFM (only 
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98% was used in this work), since the impurity content can affect native pellet signals and inter-pellet 
variability of the EPR line shape. 
LFM dosimeters are thus a promising alternative to AL at the therapy dose level, especially when using 
compact spectrometers with likely lower sensitivity. In previous works, successful application of LFM 
dosimeters at the radiotherapy dose level was reported (Adolfsson et al 2014a, 2014b, 2019, Gustafsson 
et al 2008, Vestad et al 2004, Waldeland et al 2010). However, a thorough investigation of measurement 
uncertainties in a wide dose range, as given by Anton (Anton 2006) for AL, has not yet been reported for 
LFM.  
Post-irradiation signal fading was examined for each material. The signal loss of 3%/a that was observed 
for the AL pellets is in good agreement with previously reported findings for Aérial pellets (Secerov et al 
2016). For LFM, changes in line shape and intensity were observed (figure 5), especially within the first 
five weeks following irradiation. This is partially in contradiction with the findings of previous works. 
Vestad et al reported no changes in intensity and line shape within one week after irradiation (Vestad et 
al 2003). In their work, LFM pellets were manufactured without additional binder (as in the present work) 
and then irradiated to 10 Gy by 220 kV x-rays. Komaguchi et al observed signal fading in LFM pellets of 
about 4-10% within two months after irradiation (Komaguchi et al 2007). Their pellets were pressed 
without binder and were irradiated to 1 kGy by 60Co γ-rays. The radical decay was found to be dependent 
on the ambient relative humidity. Further, it was assumed that the signal loss is due to the reaction of the 
induced CO2– radical with stoichiometrically excessive water. Costa et al observed a significant signal 
decrease of about 6.6% within the 31 days after irradiation with protons for LFM dosimeters containing 
10% paraffin as binder (Costa et al 2019). Also Adolfsson et al added 10% paraffin binder during 
manufacturing but did not observe any significant signal loss during the first month following irradiation 
to 23 Gy by a 6 MV photon beam (Adolfsson et al 2012). In their study, the pellets were stored in a 
desiccator at 33% RH. More recently, two additional minor radical species in irradiated LFM crystals were 
identified (Krivokapić et al 2015). It was shown that the EPR signal loss at ambient conditions is dominated 
by the decay of the major (CO2–) radical leading to temporal changes in EPR line shape. Our findings are 
supported and may be explained by the latter investigation. In summary, the influence of binder material 
and environmental parameters on post-irradiation signal fading in LFM is not yet fully understood and 
needs to be further investigated. Also the purity grade of LFM may affect signal fading. This was beyond 
the scope of the current study. For precise dose evaluation, however, the temporal changes in EPR line 
shape and intensity need to be known for a specific batch of LFM dosimeters and need to be taken into 
account when applying the presented spectral fitting procedure.   
Furthermore, we noted a slight non-linear dose response for LFM during calibration (figure 6). The 
regression analysis included all EPR readouts that were performed within five weeks after irradiation. 
Therefore, it cannot be ruled out that the observed non-linearity is caused by a dose dependent fading 
Page 19 of 25 AUTHOR SUBMITTED MANUSCRIPT - PMB-110037.R1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60 Ac
c
pte
 M
an
us
rip
t
S Höfel et al. Manuscript submitted to Physics in Medicine and Biology 
 
Page 20  
 
effect. Thus, our results support the assumption made by Komaguchi et al, who supposed that fading is 
due to stoichiometrically excessive water in the crystals and that fading may therefore become more 
prominent at low doses (Komaguchi et al 2007).  
The dosimetry procedure applied in the current work accounts for fading and the observed non-linearity 
(LFM), thus being able to exploit the full potential of precise low dose (<20 Gy) EPR dosimetry by using 
LFM dosimeters in a routine clinical environment. The uncertainty analysis showed that precise dose 
measurements down to 1 Gy are feasible, especially when using LFM dosimeters and multiple readouts. 
When calibrated properly, also high levels of accuracy (< 3%), as they are required in clinical dosimetry, 
are achievable. The presented dosimetry system is considered suitable for on-site applications in 
radiotherapy departments due the small-sized equipment and the restricted efforts (single calibration, 
measurement time of 10 min per pellet). However, as for any other dosimetry technique, proper staff 
training (dosimeter handling, dose evaluation, adherence to strict measuring protocols) is also a 
prerequisite for precise EPR dose measurements.  
For less-controlled circumstances and environments (e.g. in routine clinical practice or especially when 
applied in-vivo), however, the overall uncertainty of the presented dosimetry system may increase, since 
several influencing factors may have stronger impacts or need to be taken into account additionally. For 
example, our uncertainty analysis was based on an irradiation temperature of 25 ± 2.5 (2σ) °C. If 
dosimeters are applied in-vivo where irradiation temperatures of up to 37°C are expected and if no further 
temperature correction is applied, the presented procedure will lead to a systematic dose error of up to 
2.0% for both pellet types. In these situations, it is therefore recommended to estimate the mean and the 
standard deviation of the irradiation temperatures in order to perform a temperature correction 
according to (2) when determining 𝐴𝐷  and finally to consider higher values for 𝑢(𝑇) when calculating 
𝑢(𝐴𝐷) via (7). For 30 ± 7 (2σ) °C this will result in an increase of the relative dose uncertainty (1σ) by about 
0.25% with respect to the values depicted in figure 7.  
Regarding signal fading of LFM dosimeters, the temporal evolution of the EPR line shape following 
irradiation was analyzed on a weekly basis after averaging the spectra of five high dose (70 Gy) samples. 
Thus, a set of base spectra {RBc} were obtained (one on each day of measurement). The respective base 
spectrum was then used during spectral evaluation. When applying the presented dosimetry system in 
routine clinical practice, it is not necessary to irradiate additional samples in order to acquire the RBc on 
each day of measurement. We suggest to ether use the nearest available base functions out of the 
pre-known set {RBc} that was acquired during calibration or to use interpolated spectra, when samples are 
evaluated at different time points after irradiation. If the set {RBc} is used, the additional contribution to 
the relative uncertainty is estimated from the differences in the peak-to-peak amplitudes to be 
approximately 0.3 %. Applying an interpolated base spectrum may considerably reduce this additional 
uncertainty.  
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The current work presents fundamental results in order to bring EPR dosimetry from the 
calibration laboratories to hospital environments and will stimulate further research on 
applications of EPR dosimetry within clinical quality assurance programs (e.g. small field 
dosimetry, in-vivo dosimetry) in the future.  
 
5. Conclusion 
Precise dose measurements at the therapeutic dose level (1-70 Gy) are feasible on a EPR benchtop 
spectrometer by implementing a practicable EPR dosimetry procedure. In terms of uncertainty at low 
doses (< 20 Gy), the self-made LFM pellets are superior to the AL pellets received from the manufacturer 
owing to their narrower EPR spectrum and approximately doubled mass resulting in higher EPR signal 
intensities. However, careful calibration and the knowledge of fading characteristics are prerequisites 
when analyzing LFM signals. By following the elaborated dosimetry procedure, relative dose uncertainties 
of less than 3% at 1 Gy can be achieved for LFM based upon a single readout (10 min) and daily recording 
of the manganese reference signal for 1h. The uncertainties can be further decreased by averaging 
multiple dose values from independent readouts. In principle, the presented dosimetry system is 
considered suitable for future on-site applications in EBRT. However, overall uncertainties may increase 
due to less-controlled circumstances in clinical routine. For example, irradiation temperatures may be 
more variable when dosimeters are applied in-vivo.  
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